ISA Holdings Limited (JSE:ISA)

Orchard Therapeutics Income Statement

Financials in millions ZAR. Fiscal year is March - February.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Revenue	117.72	100.8	75.58	74.74	67.32
Revenue Growth (YoY)	16.79%	33.36%	1.12%	11.03%	-33.50%
Cost of Revenue	61.63	51.86	35.77	34.86	28.81
Gross Profit	56.09	48.94	39.81	39.88	38.51
Selling, General & Admin	31.93	29.1	25.88	21.13	24.37
Operating Expenses	31.93	29.1	25.88	21.13	24.41
Operating Income	24.16	19.84	13.93	18.75	14.1
Interest Expense	-0.01	-0.02	-	-	-
Interest & Investment Income	1.64	2.31	1.46	0.55	0.7
Earnings From Equity Investments	6.15	12.58	7.71	1.6	2.37
Currency Exchange Gain (Loss)	0.01	0.07	3.01	1.64	-
Other Non Operating Income (Expenses)	0.32	0.32	0.32	0.29	0.28
EBT Excluding Unusual Items	32.27	35.1	26.41	22.83	17.44
Gain (Loss) on Sale of Investments	-	-	-	-	-0.1
Gain (Loss) on Sale of Assets	0.14	-	-	-	0.1
Pretax Income	32.41	35.1	26.41	22.83	17.44
Income Tax Expense	6.35	5.57	4.54	6.47	4.49
Net Income	26.05	29.54	21.87	16.35	12.95
Net Income to Common	26.05	29.54	21.87	16.35	12.95
Net Income Growth	-11.80%	35.05%	33.74%	26.32%	-44.73%
Shares Outstanding (Basic)	156	156	156	156	156
Shares Outstanding (Diluted)	156	156	156	156	156
EPS (Basic)	0.17	0.19	0.14	0.10	0.08
EPS (Diluted)	0.17	0.19	0.14	0.10	0.08
EPS Growth	-11.80%	35.05%	33.74%	26.32%	-44.67%
Free Cash Flow	25.12	22.42	12	6.6	11.17
Free Cash Flow Per Share	0.16	0.14	0.08	0.04	0.07
Dividend Per Share	0.167	0.189	0.140	0.105	0.083
Dividend Growth	-11.64%	35.00%	33.33%	26.51%	-
Gross Margin	47.65%	48.55%	52.67%	53.36%	57.20%
Operating Margin	20.52%	19.68%	18.43%	25.09%	20.94%
Profit Margin	22.13%	29.30%	28.94%	21.88%	19.23%
Free Cash Flow Margin	21.34%	22.24%	15.88%	8.83%	16.59%
EBITDA	24.98	20.25	14.42	18.98	14.43
EBITDA Margin	21.22%	20.09%	19.08%	25.40%	21.44%
D&A For EBITDA	0.83	0.41	0.49	0.24	0.33
EBIT	24.16	19.84	13.93	18.75	14.1
EBIT Margin	20.52%	19.68%	18.43%	25.09%	20.94%
Effective Tax Rate	19.60%	15.85%	17.19%	28.35%	25.76%
Revenue as Reported	-	-	-	-	67.32

Updated May 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.